National Bank of Canada’s AbbVie ABBV Stock Holding History

National Bank of Canada’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$202M	Sell	927,136 -913,933	-50%	-$203M	0.18%	100
2025 Q4	$421M	Sell	1,841,069 -69,960	-4%	-$15.9M	0.38%	49
2025 Q3	$442M	Buy	1,911,029 +319,981	+20%	+$65.2M	0.44%	42
2025 Q2	$295M	Buy	1,591,048 +332,695	+26%	+$61.8M	0.28%	71
2025 Q1	$264M	Sell	1,258,353 -173,464	-12%	-$33.7M	0.28%	75
2024 Q4	$254M	Buy	1,431,817 +187,271	+15%	+$34.4M	0.27%	74
2024 Q3	$246M	Buy	1,244,546 +73,383	+6%	+$13.7M	0.28%	65
2024 Q2	$199M	Buy	1,171,163 +327,478	+39%	+$54.2M	0.27%	67
2024 Q1	$136M	Sell	843,685 -896,538	-52%	-$155M	0.21%	92
2023 Q4	$278M	Sell	1,740,223 -34,868	-2%	-$5.08M	0.44%	43
2023 Q3	$263M	Buy	1,775,091 +329,615	+23%	+$48.4M	0.4%	55
2023 Q2	$196M	Buy	1,445,476 +679,804	+89%	+$99.7M	0.36%	61
2023 Q1	$123M	Buy	765,672 +228,000	+42%	+$34.9M	0.3%	69
2022 Q4	$88M	Buy	537,672 +133,314	+33%	+$20.4M	0.22%	86
2022 Q3	$55.7M	Buy	404,358 +47,673	+13%	+$6.84M	0.3%	76
2022 Q2	$56.1M	Sell	356,685 -7,170	-2%	-$1.1M	0.26%	90
2022 Q1	$60.2M	Buy	363,855 +16,646	+5%	+$2.42M	0.18%	123
2021 Q4	$48.4M	Buy	+347,209	New	+$41M	0.17%	113

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

National Bank of Canada's ABBV Position: Q1 2026 in Review

National Bank of Canada reduced its AbbVie (ABBV) stake by 50% in Q1 2026, selling an estimated $203M and leaving 927,136 shares worth $202M. The position accounts for 0.18% of the portfolio, ranked #100.

National Bank of Canada first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $442M in Q3 2025. 4,082 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

National Bank of Canada held 927,136 shares of AbbVie worth $202M as of Q1 2026.
National Bank of Canada sold 913,933 AbbVie shares in Q1 2026, an estimated $203M.
AbbVie made up 0.18% of National Bank of Canada's portfolio in Q1 2026, its #100 holding.
National Bank of Canada first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
National Bank of Canada's AbbVie position peaked at $442M in Q3 2025.
4,082 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.